Healthcare & Medical Devices Global On demand · 24-48h

Global Microwave Ablation Therapy Device Market Strategic Research Report

Global Microwave Ablation Therapy Device Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Microwave Ablation Therapy Device Market
$6642025
6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Multi-channel Therapy Device, Single-channel Therapy Device

By Application: Hospital, Clinic

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Medtronic, Johnson & Johnson, Varian (Siemens), Nanjing ECO Medical Technology, Suzhou Baird Medical, AngioDynamics, Nanjing Canyon Medical, Terumo, Emblation, Beijing Surgnova Healthcare Technologies, Beijing Hygea Medical Technology, Nanjing Devon Medical, Suzhou Hengrui Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 124 pages
Market size 2025
$664
Million USD
Forecast CAGR
6%
2025-2032
Forecast 2032
$998.4
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Microwave Ablation Therapy Device market size is predicted to grow from US$ 664 million in 2025 to US$ 992 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

In 2024, global Microwave Ablation Therapy Device production reached approximately 6792 units, with an average global market price of around K US$ 88.9 per unit. A microwave ablation (MWA) therapy device is a minimally invasive tumor treatment system that utilizes high-frequency electromagnetic waves (typically 915MHz or 2450MHz) as an energy source. The device percutaneously inserts a coaxial microwave antenna (ablation needle) precisely into the center of the tumor tissue. The antenna generates a high-frequency alternating electric field in the surrounding area, causing polar molecules (primarily water molecules) within the tissue to undergo rapid friction and collisions. This rapidly generates localized high temperatures of 60-150°C, leading to irreversible coagulative necrosis of tumor cells. The necrotic tissue is eventually absorbed by the body, achieving the goal of "in-situ inactivation" of the tumor.

The prevailing market view is that microwave ablation is entering a period of rapid development as a key modality in interventional oncology. Key drivers include the increasing number of early-stage patients due to the popularization of early cancer screening, the growing acceptance of minimally invasive treatment concepts, and the clinical demand for larger and more uniform ablation zones. Future competition will extend beyond mere power specifications to intelligent surgical planning, real-time multi-dimensional treatment assessment (e.g., fusion imaging), and integration with surgical robotics. Manufacturers capable of providing integrated solutions encompassing image navigation, energy control, and treatment evaluation will secure a lasting competitive advantage.

This report presents a comprehensive overview of the global Microwave Ablation Therapy Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Multi-channel Therapy Device
  • Single-channel Therapy Device

Segment by Application

  • Hospital
  • Clinic

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Microwave Ablation Therapy Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Microwave Ablation Therapy Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$664
2025
Forecast
$998.4
2032
CAGR
6%
2025–2032
Regions
5
global
Key companies
MedtronicJohnson & JohnsonVarian (Siemens)Nanjing ECO Medical TechnologySuzhou Baird MedicalAngioDynamicsNanjing Canyon MedicalTerumo
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Multi-channel Therapy DeviceSingle-channel Therapy Device
By Application
HospitalClinic

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Multi-channel Therapy Device
  • 3.1.3 Single-channel Therapy Device
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Medtronic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Johnson & Johnson
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Varian (Siemens)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Nanjing ECO Medical Technology
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Suzhou Baird Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 AngioDynamics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Nanjing Canyon Medical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Terumo
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Emblation
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Beijing Surgnova Healthcare Technologies
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Beijing Hygea Medical Technology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Nanjing Devon Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Suzhou Hengrui Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Microwave Ablation Therapy Device market size?
The global Microwave Ablation Therapy Device market is estimated at US$ 664 million in 2025 (base year) and is projected to reach US$ 992 million by 2032.
What growth rate is expected for the Microwave Ablation Therapy Device market through 2032?
The market is expected to grow at a CAGR of 6.0% from 2026 to 2032, expanding from US$ 664 million in 2025 to US$ 992 million in 2032, roughly 1.5 times its base-year value.
How is Microwave Ablation Therapy Device defined?
In 2024, global Microwave Ablation Therapy Device production reached approximately 6792 units, with an average global market price of around K US$ 88.9 per unit. A microwave ablation (MWA) therapy device is a minimally invasive tumor treatment system that utilizes high-frequency electromagnetic waves (typically 915MHz or 2450MHz) as an energy source. The device percutaneously inserts a coaxial microwave antenna (ablation needle) precisely into the center of the tumor tissue.
What are the main segments of the Microwave Ablation Therapy Device market by type?
By type, the market is segmented into Multi-channel Therapy Device and Single-channel Therapy Device.
Which applications drive demand in the Microwave Ablation Therapy Device market?
Key applications covered include Hospital and Clinic.
Who are the key players in the Microwave Ablation Therapy Device market?
Key players profiled include Medtronic, Johnson & Johnson, Varian (Siemens), Nanjing ECO Medical Technology, Suzhou Baird Medical, AngioDynamics, Nanjing Canyon Medical and Terumo, among 13 companies covered in total.
Which regions and countries are covered for Microwave Ablation Therapy Device?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Microwave Ablation Therapy Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital and Clinic, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Microwave Ablation Therapy Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.